A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Cutaneous Melanoma · Mucosal Melanoma · Cutaneous Squamous Cell Carcinoma (CSCC) · Merkel Cell Carcinoma of Skin · Basal Cell Carcinoma of Skin

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Universitätsklinikum Würzburg, Würzburg, Bavaria, Germany
Fachklinik Hornheide, Münster, North Rhine-Westphalia, Germany

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

A Study of MGC026 in Participants With Advanced Solid Tumors

Advanced Solid Tumor · Advanced Cancer · Metastatic Cancer

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Grand Rapids, United States

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Tumor, Solid · Pancreatic Cancer · Melanoma

Abroad (travel likely)RecruitingPHASE1

Chapel Hill, United States

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

Melanoma · Unresectable Solid Tumors · Neoplasms

Abroad (travel likely)RecruitingPHASE1

Chicago, United States · Pittsburgh, United States